Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Achieve Life Sciences Inc (NQ: ACHV )

5.123 -0.517 (-9.17%)
Streaming Delayed Price Updated: 12:07 PM EDT, Aug 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49,265
Open 5.510
Bid (Size) 5.130 (2)
Ask (Size) 5.260 (1)
Prev. Close 5.640
Today's Range 5.090 - 5.510
52wk Range 4.780 - 10.09
Shares Outstanding 9,681,855
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  On Friday, 39 companies reached new 52-week lows. 
Via Benzinga
Achieve Life Sciences: Q1 Earnings Insights
Achieve Life Sciences (NASDAQ:ACHV) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga

Performance

YTD
-37.98%
-37.98%
1 Month
-7.19%
-7.19%
3 Month
-24.55%
-24.55%
6 Month
-31.69%
-31.69%
1 Year
-24.77%
-24.77%

More News

Read More
Achieve Life Sciences Aces Pivotal Cytisinicline Study In Smoking Cessation
Via Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Via Benzinga
Earnings Scheduled For March 10, 2022
Via Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
From MicroCap Rodeo
Via AccessWire
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
From MicroCap Rodeo
Via AccessWire
Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation
Via Benzinga
Achieve Life Sciences Secures $25M Loan Facility To Fund Smoking Cessation Program
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
Achieve Life Sciences To Start Cytisinicline's Trial For Nicotine E-cigarette Cessation
Via Benzinga
Exposures Product Safety
Achieve Life Sciences to Participate in Upcoming Investor Conferences
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death
Exposures Death
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Via Benzinga
Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property
Achieve Life Sciences to Participate in Two Upcoming Investor Conferences
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death
Exposures Death
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Via Benzinga
Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
From Achieve Life Sciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures COVID-19 Death Intellectual Property
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.